β-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulation

被引:49
作者
Cai, Yan [2 ,3 ]
Xiong, Kun [2 ]
Zhang, Xue-Mei [1 ,4 ]
Cai, Huaibin [5 ]
Luo, Xue-Gang [2 ]
Feng, Jia-Chun [4 ]
Clough, Richard W. [1 ]
Struble, Robert G. [6 ]
Patrylo, Peter R. [1 ,3 ]
Chu, Yaping [7 ]
Kordower, Jeffrey H. [7 ]
Yan, Xiao-Xin [1 ]
机构
[1] So Illinois Univ, Sch Med Carbondale, Dept Anat, Carbondale, IL 62901 USA
[2] Cent S Univ, Xiangya Med Sch, Dept Anat & Neurobiol, Changsha, Hunan, Peoples R China
[3] So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA
[4] Jilin Univ, Hosp 1, Dept Neurol, Changchun 130023, Jilin, Peoples R China
[5] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA
[6] So Illinois Univ, Sch Med, Ctr Alzheimers Dis, Carbondale, IL 62901 USA
[7] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA
关键词
aging; dementia; hypometabolism; neuritic plaque; neuroplasticity; non-human primate; MILD COGNITIVE IMPAIRMENT; A-BETA; CEREBROSPINAL-FLUID; DYSTROPHIC NEURITES; SECRETASE BACE1; RHESUS-MONKEYS; PLAQUES; PROTEIN; PATHOLOGY; ENZYME;
D O I
10.1111/j.1460-9568.2010.07376.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) is the most common dementia-causing disorder in the elderly; it may be related to multiple risk factors, and is characterized pathologically by cerebral hypometabolism, paravascular beta-amyloid peptide (A beta) plaques, neuritic dystrophy, and intra-neuronal aggregation of phosphorylated tau. To explore potential pathogenic links among some of these lesions, we examined beta-secretase-1 (BACE1) alterations relative to A beta deposition, neuritic pathology and vascular organization in aged monkey and AD human cerebral cortex. Western blot analyses detected increased levels of BACE1 protein and beta-site-cleavage amyloid precursor protein C-terminal fragments in plaque-bearing human and monkey cortex relative to controls. In immunohistochemistry, locally elevated BACE1 immunoreactivity (IR) occurred in AD but not in control human cortex, with a trend for increased overall density among cases with greater plaque pathology. In double-labeling preparations, BACE1 IR colocalized with immunolabeling for A beta but not for phosphorylated tau. In perfusion-fixed monkey cortex, locally increased BACE1 IR co-existed with intra-axonal and extracellular A beta IR among virtually all neuritic plaques, ranging from primitive to typical cored forms. This BACE1 labeling localized to swollen/sprouting axon terminals that might co-express one or another neuronal phenotype markers (GABAergic, glutamatergic, cholinergic, or catecholaminergic). Importantly, these BACE1-labeled dystrophic axons resided near to or in direct contact with blood vessels. These findings suggest that plaque formation in AD or normal aged primates relates to a multisystem axonal pathogenesis that occurs in partnership with a potential vascular or metabolic deficit. The data provide a mechanistic explanation for why senile plaques are present preferentially near the cerebral vasculature.
引用
收藏
页码:1223 / 1238
页数:16
相关论文
共 58 条
[1]   An energy budget for signaling in the grey matter of the brain [J].
Attwell, D ;
Laughlin, SB .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2001, 21 (10) :1133-1145
[2]   Consequence of A immunization on the vasculature of human Alzheimers disease brain [J].
Boche, D. ;
Zotova, E. ;
Weller, R. O. ;
Love, S. ;
Neal, J. W. ;
Pickering, R. M. ;
Wilkinson, D. ;
Holmes, C. ;
Nicoll, J. A. R. .
BRAIN, 2008, 131 :3299-3310
[3]   Modeling an Anti-Amyloid Combination Therapy for Alzheimer's Disease [J].
Chow, Vivian W. ;
Savonenko, Alena V. ;
Melnikova, Tatiana ;
Kim, Hyunsu ;
Price, Donald L. ;
Li, Tong ;
Wong, Philip C. .
SCIENCE TRANSLATIONAL MEDICINE, 2010, 2 (13) :13ra1
[4]   Age-associated increases of α-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion:: Is this the target for Parkinson's disease? [J].
Chu, Yaping ;
Kordower, Jeffrey H. .
NEUROBIOLOGY OF DISEASE, 2007, 25 (01) :134-149
[5]   Basal Cerebral Metabolism May Modulate the Cognitive Effects of Aβ in Mild Cognitive Impairment: An Example of Brain Reserve [J].
Cohen, Ann D. ;
Price, Julie C. ;
Weissfeld, Lisa A. ;
James, Jeffrey ;
Rosario, Bedda L. ;
Bi, Wenzhu ;
Nebes, Robert D. ;
Saxton, Judith A. ;
Snitz, Beth E. ;
Aizenstein, Howard A. ;
Wolk, David A. ;
DeKosky, Steven T. ;
Mathis, Chester A. ;
Klunk, William E. .
JOURNAL OF NEUROSCIENCE, 2009, 29 (47) :14770-14778
[6]   Linking vascular disorders and Alzheimer's disease: Potential involvement of BACE1 [J].
Cole, Sarah L. ;
Vassar, Robert .
NEUROBIOLOGY OF AGING, 2009, 30 (10) :1535-1544
[7]   The secretases: enzymes with therapeutic potential in Alzheimer disease [J].
De Strooper, Bart ;
Vassar, Robert ;
Golde, Todd .
NATURE REVIEWS NEUROLOGY, 2010, 6 (02) :99-107
[8]   The morphological phenotype of β-amyloid plaques and associated neuritic changes in Alzheimer's disease [J].
Dickson, TC ;
Vickers, JC .
NEUROSCIENCE, 2001, 105 (01) :99-107
[9]   Classification and basic pathology of Alzheimer disease [J].
Duyckaerts, Charles ;
Delatour, Benoit ;
Potier, Marie-Claude .
ACTA NEUROPATHOLOGICA, 2009, 118 (01) :5-36
[10]   Increased CSF-BACE 1 activity is associated with ApoE-ε4 genotype in subjects with mild cognitive impairment and Alzheimer's disease [J].
Ewers, Michael ;
Zhong, Zhenyu ;
Buerger, Katharina ;
Wallin, Anders ;
Blennow, Kaj ;
Teipel, Stefan J. ;
Shen, Yong ;
Hampel, Harald .
BRAIN, 2008, 131 :1252-1258